1. Home
  2. ETNB vs CCU Comparison

ETNB vs CCU Comparison

Compare ETNB & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • CCU
  • Stock Information
  • Founded
  • ETNB 2018
  • CCU 1850
  • Country
  • ETNB United States
  • CCU Chile
  • Employees
  • ETNB N/A
  • CCU N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • CCU Beverages (Production/Distribution)
  • Sector
  • ETNB Health Care
  • CCU Consumer Staples
  • Exchange
  • ETNB Nasdaq
  • CCU Nasdaq
  • Market Cap
  • ETNB 2.2B
  • CCU 2.2B
  • IPO Year
  • ETNB 2019
  • CCU 1992
  • Fundamental
  • Price
  • ETNB $14.80
  • CCU $12.40
  • Analyst Decision
  • ETNB Buy
  • CCU Strong Sell
  • Analyst Count
  • ETNB 10
  • CCU 1
  • Target Price
  • ETNB $22.31
  • CCU $10.00
  • AVG Volume (30 Days)
  • ETNB 3.5M
  • CCU 129.5K
  • Earning Date
  • ETNB 11-07-2025
  • CCU 11-10-2025
  • Dividend Yield
  • ETNB N/A
  • CCU 2.45%
  • EPS Growth
  • ETNB N/A
  • CCU 38.53
  • EPS
  • ETNB N/A
  • CCU 0.44
  • Revenue
  • ETNB N/A
  • CCU $3,254,866,554.00
  • Revenue This Year
  • ETNB N/A
  • CCU $7.11
  • Revenue Next Year
  • ETNB N/A
  • CCU $4.64
  • P/E Ratio
  • ETNB N/A
  • CCU $14.14
  • Revenue Growth
  • ETNB N/A
  • CCU 19.82
  • 52 Week Low
  • ETNB $4.16
  • CCU $10.65
  • 52 Week High
  • ETNB $15.06
  • CCU $15.75
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 75.79
  • CCU 56.90
  • Support Level
  • ETNB $14.74
  • CCU $12.20
  • Resistance Level
  • ETNB $14.85
  • CCU $12.71
  • Average True Range (ATR)
  • ETNB 0.06
  • CCU 0.27
  • MACD
  • ETNB -0.20
  • CCU 0.08
  • Stochastic Oscillator
  • ETNB 33.33
  • CCU 79.41

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About CCU Compania Cervecerias Unidas S.A.

United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.

Share on Social Networks: